Kyowa Kirin Co Ltd logo

Kyowa Kirin Co Ltd

TSE:4151 (Japan)  
円 2568.00 (-0.85%) May 24
23.84
P/B:
1.70
Market Cap:
円 1.38T ($ 8.80B)
Enterprise V:
円 997.47B ($ 6.36B)
Volume:
844.40K
Avg Vol (2M):
1.07M
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Kyowa Kirin Co Ltd ( ) from 1990 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Kyowa Kirin stock (TSE:4151) PE ratio as of May 26 2024 is 23.84. More Details

Kyowa Kirin Co Ltd (TSE:4151) PE Ratio (TTM) Chart

To

Kyowa Kirin Co Ltd (TSE:4151) PE Ratio (TTM) Historical Data

Total 1233
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Kyowa Kirin PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-26 23.8 2024-03-19 26.8
2024-05-24 23.8 2024-03-18 26.8
2024-05-23 24.0 2024-03-15 26.3
2024-05-22 23.8 2024-03-14 26.1
2024-05-21 24.1 2024-03-13 26.2
2024-05-20 24.3 2024-03-12 26.3
2024-05-17 24.3 2024-03-11 26.6
2024-05-16 24.6 2024-03-08 26.3
2024-05-15 24.5 2024-03-07 26.6
2024-05-14 25.0 2024-03-06 27.0
2024-05-13 24.8 2024-03-05 27.3
2024-05-10 24.8 2024-03-04 27.3
2024-05-09 24.6 2024-03-01 27.4
2024-05-08 24.4 2024-02-29 27.6
2024-05-07 24.9 2024-02-28 27.4
2024-05-02 24.8 2024-02-27 27.4
2024-05-01 24.8 2024-02-26 27.1
2024-04-30 24.6 2024-02-22 26.7
2024-04-26 24.4 2024-02-21 26.7
2024-04-25 24.4 2024-02-20 26.9
2024-04-24 24.6 2024-02-19 26.5
2024-04-23 24.6 2024-02-16 26.8
2024-04-22 24.6 2024-02-15 26.0
2024-04-19 24.2 2024-02-14 25.8
2024-04-18 24.5 2024-02-13 26.2
2024-04-17 24.4 2024-02-09 25.6
2024-04-16 24.7 2024-02-08 25.1
2024-04-15 24.8 2024-02-07 21.1
2024-04-12 24.9 2024-02-06 21.6
2024-04-11 24.6 2024-02-05 21.5
2024-04-10 24.2 2024-02-02 21.5
2024-04-09 24.4 2024-02-01 21.4
2024-04-08 24.5 2024-01-31 21.7
2024-04-05 24.6 2024-01-30 21.4
2024-04-04 24.3 2024-01-29 21.6
2024-04-03 24.4 2024-01-26 21.7
2024-04-02 24.0 2024-01-25 21.9
2024-04-01 24.4 2024-01-24 22.1
2024-03-29 25.0 2024-01-23 22.1
2024-03-28 25.2 2024-01-22 21.9
2024-03-27 25.7 2024-01-19 21.8
2024-03-26 25.4 2024-01-18 22.1
2024-03-25 25.4 2024-01-17 22.2
2024-03-22 25.9 2024-01-16 22.5
2024-03-21 26.4 2024-01-15 22.7

Kyowa Kirin Co Ltd (TSE:4151) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.